<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on November 19, 2021</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT02887053</url>
  </required_header>
  <id_info>
    <org_study_id>2008-A01209-46</org_study_id>
    <nct_id>NCT02887053</nct_id>
  </id_info>
  <brief_title>Methodological Developments for Magnetic Resonance Imaging (MRI)</brief_title>
  <acronym>METHODO</acronym>
  <official_title>Développement Méthodologique de l'Imagerie Par Résonance Magnétique (IRM)</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Central Hospital, Nancy, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>Central Hospital, Nancy, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this study is to optimize clinical MR protocols and to validate MR acquisition&#xD;
      parameters.&#xD;
    </textblock>
  </brief_summary>
  <overall_status>Recruiting</overall_status>
  <start_date type="Actual">November 2008</start_date>
  <completion_date type="Anticipated">June 2022</completion_date>
  <primary_completion_date type="Anticipated">June 2022</primary_completion_date>
  <phase>N/A</phase>
  <study_type>Interventional</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <allocation>N/A</allocation>
    <intervention_model>Single Group Assignment</intervention_model>
    <primary_purpose>Other</primary_purpose>
    <masking>None (Open Label)</masking>
  </study_design_info>
  <primary_outcome>
    <measure>Image quality based on standard imaging quality criteria</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>Image quality criteria will be :&#xD;
Signal to Noise Ratio and Contrast to Noise Ratio measured in arbitrary units.&#xD;
absence of blurring and artefacts will be assessed by at least one radiologist according to an ordinal scale</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>T1/T2 Quantitative sub studies</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>For quantitative studies such as T1/T2 studies a T1/T2 quantification will be calculated. These parameters will be reported in ms.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Brain Functional MRI sub studies</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>For functional MRI studies, brain activity will be described in terms of brain localisation based on blood oxygen level-dependent signal variation and its intensity.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac function MRI sub studies: volume</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>For cardiac imaging, cardiac function will be evaluated. Parameters such as left ventricle (LV) and right ventricle (RV) end-diastolic volumes end-systolic volumes will be measured and reported in mL/m².</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac mass MRI sub studies: mass</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>For cardiac imaging, cardiac function will be evaluated. LV and RV mass index will be measured and reported in g/m2.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Cardiac function MRI sub studies: ejection fraction</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>For cardiac imaging, cardiac function will be evaluated. Ejection fraction for both ventricles will be calculated and reported in %.</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diffusion weighted MRI sub studies</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>For diffusion studies, the apparent diffusion coefficient (ADC) whic is a measure of the magnitude of diffusion (of water molecules) within tissue will be estimated (mm2/s).</description>
  </secondary_outcome>
  <secondary_outcome>
    <measure>Diffusion tensor MRI sub studies</measure>
    <time_frame>6 months after the last inclusion</time_frame>
    <description>The fractional anisotropy (FA) which is a scalar value between zero and one, which describes the degree of anisotropy of a diffusion process, could also be estimated.</description>
  </secondary_outcome>
  <number_of_arms>1</number_of_arms>
  <enrollment type="Anticipated">1740</enrollment>
  <condition>Healthy Subjects</condition>
  <arm_group>
    <arm_group_label>All subjects</arm_group_label>
    <arm_group_type>Experimental</arm_group_type>
    <description>All subjects will have an MRI examination</description>
  </arm_group>
  <intervention>
    <intervention_type>Device</intervention_type>
    <intervention_name>MRI</intervention_name>
    <arm_group_label>All subjects</arm_group_label>
  </intervention>
  <eligibility>
    <criteria>
      <textblock>
        Inclusion Criteria:&#xD;
&#xD;
          -  to be over 18 year-old,&#xD;
&#xD;
          -  to be able to give an informed consent,&#xD;
&#xD;
          -  to have underwent a pre-inclusion medical examination,&#xD;
&#xD;
          -  to present no contraindication to MR examination,&#xD;
&#xD;
          -  to be enrolled in a social security plan.&#xD;
&#xD;
        Exclusion Criteria:&#xD;
&#xD;
          -  subject refusal,&#xD;
&#xD;
          -  subject under a measure of legal protection,&#xD;
&#xD;
          -  any contraindication to MR examination (active medical device, ferromagnetic foreign&#xD;
             body, pregnancy, morbid obesity, claustrophobia, … ).&#xD;
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Valérie Laurent, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHRU de Nancy</affiliation>
  </overall_official>
  <overall_official>
    <last_name>Jacques Felblinger, MD,PhD</last_name>
    <role>Principal Investigator</role>
    <affiliation>CHRU de Nancy</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Valérie Laurent, MD,PhD</last_name>
    <email>v.laurent@chru-nancy.fr</email>
  </overall_contact>
  <overall_contact_backup>
    <last_name>Gabriela Hossu, PhD</last_name>
    <email>g.hossu@chru-nancy.fr</email>
  </overall_contact_backup>
  <location>
    <facility>
      <name>CHRU de Nancy</name>
      <address>
        <city>Nancy</city>
        <zip>5400</zip>
        <country>France</country>
      </address>
    </facility>
    <status>Recruiting</status>
    <contact>
      <last_name>Valerie Laurent, Md, PhD</last_name>
    </contact>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>May 2021</verification_date>
  <study_first_submitted>July 15, 2016</study_first_submitted>
  <study_first_submitted_qc>August 31, 2016</study_first_submitted_qc>
  <study_first_posted type="Estimate">September 1, 2016</study_first_posted>
  <last_update_submitted>May 20, 2021</last_update_submitted>
  <last_update_submitted_qc>May 20, 2021</last_update_submitted_qc>
  <last_update_posted type="Actual">May 21, 2021</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Central Hospital, Nancy, France</investigator_affiliation>
    <investigator_full_name>Valérie LAURENT</investigator_full_name>
    <investigator_title>Principal Investigator</investigator_title>
  </responsible_party>
  <keyword>MRI</keyword>
  <keyword>Healthy subjects</keyword>
  <patient_data>
    <sharing_ipd>No</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

